What do you want to do today?
video_library
Watch On Demand
auto_awesome_motion
Discover Series
person_search
Search KOLs
campaign
Meet our Ambassadors
group_work
Meet Societies
handshake
Meet Partners
video_library
OnDemand
auto_awesome_motion
Series
person_search
Faculty
campaign
Ambassa-
dors
group_work
Societies
handshake
Partners
Chat keyboard_arrow_down
Description keyboard_arrow_down
Non-Muscle Invasive Bladder Cancer (NMIBC) remains a challenging condition, and the treatment landscape continues to evolve with exciting advances. Being the most common type of bladder cancer, managing it presents several challenges, and the need for ongoing innovation in treatment and patient care is critical.

  1. Welcome & Introduction - Dr. Juan Luis Vásquez (Denmark)

  2. Novel Strategies for Outpatient Care - Dr. Juan Luis Vásquez (Denmark)

  3. How Advanced Imaging Is Supporting Treatment Outcomes - Prof. Bernard Malavaud (France)

  4. Optimizing Bladder Cancer Treatment – Miss Helena Burden (UK)

  5. Panel Discussion - All faculty moderated by Dr. Juan Luis Vásquez (Denmark)

  6. Closing Remarks - Dr. Juan Luis Vásquez (Denmark)
Faculty keyboard_arrow_down
Ms. Helena Burden MbChB, MRCS, FRCS, MD, Consultant Urological Surgeon, Bristol Urological Institute, Southmead Hospital, UK Urology
Dr. Bernard Malavaud MD, PhD, FEBU, Professor of Urology, Toulouse University; Head of Onco-Urology, Toulouse Cancer Institute, France Urology
Dr. Juan Luis Vásquez MD, PhD, Senior Consultant and Chief, Urothelial Cancer Team, Zealand University Hospital Roskilde; Associate Professor, University of Copenhagen, Denmark Urology
In collaboration with keyboard_arrow_down
Olympus
Related Content keyboard_arrow_down